Market Insights: Procept BioRobotics Corp (PRCT)’s Notable Gain of 4.41, Closing at 81.46

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Procept BioRobotics Corp’s stock clocked out at $81.46, up 4.41% from its previous closing price of $78.02. In other words, the price has increased by $4.41 from its previous closing price. On the day, 0.75 million shares were traded. PRCT stock price reached its highest trading level at $82.85 during the session, while it also had its lowest trading level at $77.75.

Ratios:

To gain a deeper understanding of PRCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.49 and its Current Ratio is at 7.51. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.31.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 11, 2023, initiated with a Overweight rating and assigned the stock a target price of $42.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 17 ’24 when Nouri Alaleh sold 10,000 shares for $62.18 per share. The transaction valued at 621,764 led to the insider holds 52,472 shares of the business.

Shiblaq Hisham sold 26,046 shares of PRCT for $1,777,499 on Jun 10 ’24. The EVP, Chief Comm. Officer now owns 55,860 shares after completing the transaction at $68.24 per share. On May 01 ’24, another insider, Krummel Thomas M, who serves as the Director of the company, sold 20,000 shares for $60.00 each. As a result, the insider received 1,200,000 and left with 45,631 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 4230405120 and an Enterprise Value of 4099267072. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.96 while its Price-to-Book (P/B) ratio in mrq is 16.79. Its current Enterprise Value per Revenue stands at 23.215 whereas that against EBITDA is -39.108.

Stock Price History:

Over the past 52 weeks, PRCT has reached a high of $85.81, while it has fallen to a 52-week low of $24.83. The 50-Day Moving Average of the stock is 25.58%, while the 200-Day Moving Average is calculated to be 53.04%.

Shares Statistics:

It appears that PRCT traded 666.50K shares on average per day over the past three months and 1052700 shares per day over the past ten days. A total of 50.77M shares are outstanding, with a floating share count of 48.87M. Insiders hold about 5.89% of the company’s shares, while institutions hold 84.75% stake in the company. Shares short for PRCT as of 1722384000 were 5231884 with a Short Ratio of 8.51, compared to 1719532800 on 5042276. Therefore, it implies a Short% of Shares Outstanding of 5231884 and a Short% of Float of 13.83.

Most Popular